Suppr超能文献

与PSMA PET/CT和多参数MRI检测前列腺癌相关的临床、病理和影像变量

Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric MRI.

作者信息

Sonni Ida, Weiner Adam B, Doddipalli Sahith, Deol Madhvi, Ban David, Kim Hye Ok, Grogan Tristan, Ahuja Preeti, Barroso Nashla, Zong Yang, Soin Priti, Sisk Anthony, Czernin Johannes, Hsu William, Calais Jeremie, Reiter Robert E, Raman Steven S

机构信息

Department of Radiological Sciences, UCLA, Los Angeles, California;

Department of Experimental and Clinical Medicine, University Magna Graecia, Catanzaro, Italy.

出版信息

J Nucl Med. 2024 Dec 3;65(12):1923-1931. doi: 10.2967/jnumed.124.268443.

Abstract

Multiparametric MRI (mpMRI) and prostate-specific membrane antigen (PSMA) PET/CT are complementary imaging modalities used in the presurgical evaluation of patients with prostate cancer (PCa). The purpose of this study was to characterize clinically significant PCa (csPCa) detected and not detected by PSMA PET/CT and mpMRI, focusing on tumors detected solely by PSMA PET/CT and overlooked by mpMRI. We conducted a single-center, retrospective analysis of patients who underwent both PSMA PET/CT and mpMRI within 3 mo of each other and before radical prostatectomy. Two nuclear medicine physicians and 2 radiologists, in a masked manner, independently contoured PCa lesions on PSMA PET/CT and mpMRI, respectively. A consensus read was done with a third reader for each modality, and a majority rule was applied (2:1). After centralized imaging, a pathologic review was done by a genitourinary pathologist. We assessed agreement between imaging modalities and correlation with pathology. Logistic regression models explored associations between clinicopathologic variables and tumor detection on imaging. In total, 132 csPCa tumors from 100 patients were identified on surgical pathology. PSMA PET/CT showed higher lesion-level (87% vs. 80%) and patient-level (98% vs. 94%) sensitivity than mpMRI. Tumors detected on both imaging modalities were larger and had higher grade groups than those not detected by one or both imaging modalities. On multivariable analysis, csPCa tumors undetected by mpMRI but detected by PSMA PET/CT were smaller than those detected by both modalities. Most tumors showing aggressive pathologic features, such as the large cribriform pattern (94.7%) and the intraductal carcinoma (96%), were correctly detected by both imaging modalities. Limitations included selection bias in a surgical cohort. PSMA PET/CT tends to detect smaller csPCa not detected by mpMRI. Larger tumors on pathology with higher grade groups are more likely to be correctly detected by both imaging modalities. These findings provide insights for refining presurgical evaluation strategies in PCa.

摘要

多参数磁共振成像(mpMRI)和前列腺特异性膜抗原(PSMA)PET/CT是用于前列腺癌(PCa)患者术前评估的互补成像方式。本研究的目的是对PSMA PET/CT和mpMRI检测到和未检测到的具有临床意义的前列腺癌(csPCa)进行特征描述,重点关注仅由PSMA PET/CT检测到而被mpMRI遗漏的肿瘤。我们对在根治性前列腺切除术之前3个月内彼此间隔3个月内接受PSMA PET/CT和mpMRI检查的患者进行了单中心回顾性分析。两名核医学医师和两名放射科医师分别以盲法独立在PSMA PET/CT和mpMRI上勾勒出PCa病变。对每种检查方式由第三位阅片者进行一致性阅片,并采用多数规则(2:1)。在集中阅片后,由泌尿生殖病理学家进行病理复查。我们评估了成像方式之间的一致性以及与病理的相关性。逻辑回归模型探讨了临床病理变量与成像上肿瘤检测之间的关联。在手术病理中总共鉴定出100例患者的132个csPCa肿瘤。PSMA PET/CT显示出比mpMRI更高的病灶水平(87%对80%)和患者水平(98%对94%)敏感性。在两种成像方式上均检测到的肿瘤比未被一种或两种成像方式检测到的肿瘤更大且分级更高。在多变量分析中,mpMRI未检测到但PSMA PET/CT检测到的csPCa肿瘤比两种方式均检测到的肿瘤更小。大多数表现出侵袭性病理特征的肿瘤,如大筛状模式(94.7%)和导管内癌(96%),在两种成像方式上均被正确检测到。局限性包括手术队列中的选择偏倚。PSMA PET/CT倾向于检测到mpMRI未检测到的较小的csPCa。病理上更大且分级更高的肿瘤更有可能被两种成像方式正确检测到。这些发现为完善PCa的术前评估策略提供了见解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验